Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe LANCET REG HEALTH-EU
European Expert Recommendations on Teclistamab Management for Relapsed or Refractory Multiple Myeloma CL LYMPH MYELOM LEUK
In Vitro Evidence of Therapy-Induced Suppression of Prothrombotic and Proinflammatory Phenotypes in Severe COVID-19 THROMB HAEMOSTASIS
m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsis Front Immunol
Allo-HCT with post-transplant cyclophosphamide in older adults: similar safety and a viable option compared to younger adults Front Immunol
Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates Mater Today Bio
Prostate Cancer Incidence by Age and Clinicopathological Characteristics: A Population-Based Study in Girona, Spain, 2010 to 2021 CLIN GENITOURIN CANC
EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura Front Immunol
Polygenic risk for white matter hyperintensities is associated with early cerebrovascular events partly through hemodynamic measures in cognitively unimpaired middle-aged and older adults with low cardiovascular risk Front Neurol